menu search

TCRT / 5 Stocks to Buy as the Drug Industry Bets Big on Innovation

5 Stocks to Buy as the Drug Industry Bets Big on Innovation
Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions to one's portfolio. Read More
Posted: Jan 18 2023, 10:33
Author Name: Zacks Investment Research
Views: 102259

TCRT News  

Alaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65%

By Zacks Investment Research
August 16, 2023

Alaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65%

Due to a lack of funding needs, Alaunos (TCRT) decides to end its only clinical study. The company will instead focus on its hunTR TCR discovery platf more_horizontal

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April

By GlobeNewsWire
March 29, 2023

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April

HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor more_horizontal

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

By GlobeNewsWire
February 28, 2023

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

HOUSTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-f more_horizontal

Is Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
January 24, 2023

Is Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?

Here is how Alaunos (TCRT) and Autolus Therapeutics PLC Sponsored ADR (AUTL) have performed compared to their sector so far this year. more_horizontal

5 Stocks to Buy as the Drug Industry Bets Big on Innovation

By Zacks Investment Research
January 18, 2023

5 Stocks to Buy as the Drug Industry Bets Big on Innovation

Innovation is expected to continue driving growth in the Medical-Drugs industry in 2023. DYN, SLN, TCRT, ASRT and ACER may prove to be good additions more_horizontal

Alaunos Therapeutics Still Waiting For Home Run

By Seeking Alpha
November 21, 2022

Alaunos Therapeutics Still Waiting For Home Run

First-in-human data from two patients using TCR-T cell therapy produced, at best, one partial response. While not targeting solid tumors, approved CAR more_horizontal

Alaunos Therapeutics, Inc. (TCRT) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 14, 2022

Alaunos Therapeutics, Inc. (TCRT) Q3 2022 Earnings Call Transcript

Alaunos Therapeutics, Inc. (NASDAQ:TCRT ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Alex Lobo - Stern Investo more_horizontal

Why Alaunos Therapeutics Topped the Market on Tuesday

By The Motley Fool
September 6, 2022

Why Alaunos Therapeutics Topped the Market on Tuesday

A specialty cancer therapy developed by the company shows some rather promising results. more_horizontal


Search within

Pages Search Results: